498 related articles for article (PubMed ID: 20432659)
1. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].
Gil de Miguel A
An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659
[TBL] [Abstract][Full Text] [Related]
2. [Pain in herpes zoster: Prevention and treatment].
Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P
Semergen; 2017; 43(4):318-327. PubMed ID: 27053513
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
4. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
5. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.
Amirthalingam G; Andrews N; Keel P; Mullett D; Correa A; de Lusignan S; Ramsay M
Lancet Public Health; 2018 Feb; 3(2):e82-e90. PubMed ID: 29276017
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
Hoshi SL; Kondo M; Okubo I
Vaccine; 2017 May; 35(24):3264-3271. PubMed ID: 28479176
[TBL] [Abstract][Full Text] [Related]
8. [Herpes zoster and post-herpetic neuralgia in the elderly: Particularities in prevention, diagnosis, and treatment].
García-González AI; Rosas-Carrasco O
Gac Med Mex; 2017; 153(1):92-101. PubMed ID: 28128811
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of herpes zoster by vaccination].
Kofoed K; Rønholt F; Gerstoft J; Sand C
Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
[TBL] [Abstract][Full Text] [Related]
10. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review.
Koshy E; Mengting L; Kumar H; Jianbo W
Indian J Dermatol Venereol Leprol; 2018; 84(3):251-262. PubMed ID: 29516900
[TBL] [Abstract][Full Text] [Related]
12. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
13. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
Johnson RW
Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648
[TBL] [Abstract][Full Text] [Related]
14. [Herpes zoster in old adults].
Lang PO; Belmin J; Michel JP
Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069
[TBL] [Abstract][Full Text] [Related]
15. Varicella zoster vaccines.
Creed R; Satyaprakash A; Ravanfar P
Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine: A health economic evaluation for Switzerland.
Blank PR; Ademi Z; Lu X; Szucs TD; Schwenkglenks M
Hum Vaccin Immunother; 2017 Jul; 13(7):1495-1504. PubMed ID: 28481678
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccine: a protection for the elderly.
Di Pietro A; Facciolà A; Visalli G
Ann Ig; 2018; 30(4 Supple 1):23-27. PubMed ID: 30062376
[TBL] [Abstract][Full Text] [Related]
18. Vaccination for quality of life: herpes-zoster vaccines.
Lang PO; Aspinall R
Aging Clin Exp Res; 2021 Apr; 33(4):1113-1122. PubMed ID: 31643072
[TBL] [Abstract][Full Text] [Related]
19. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
20. [Zoster and postherpetic neuralgia: vaccine prevention is available].
Belmin J; Jarzebowski W; Lafuente-Lafuente C
Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13 Suppl 2():15-20. PubMed ID: 26967927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
